scholarly journals Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir: Randomized, open-label, clinical trial of efficacy and safety in patients with type 2 diabetes treated with metformin alone or in combination with sulfonylureas

Diabetes Care ◽  
2012 ◽  
Vol 36 (5) ◽  
pp. 1368-1376 ◽  
Author(s):  
M. Davies ◽  
S. Heller ◽  
S. Sreenan ◽  
H. Sapin ◽  
O. Adetunji ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Insulin Detemir ◽  
Efficacy And Safety ◽  
Open Label ◽  
Daily Insulin

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

2018 ◽  
Vol 20 (9) ◽  
pp. 2229-2237 ◽  
Author(s):  
Priscilla A. Hollander ◽  
Wendy L. Carofano ◽  
Raymond L.H. Lam ◽  
Gregory T. Golm ◽  
Roy Eldor ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Insulin Glargine ◽  
Efficacy And Safety ◽  
Open Label

scholarly journals Efficacy and safety of repaglinide added to sitagliptin in Japanese patients with type 2 diabetes: A randomized 24-week open-label clinical trial

2016 ◽  
Vol 63 (12) ◽  
pp. 1087-1098 ◽  
Author(s):  
Akihiro Nishimura ◽  
Shuki Usui ◽  
Naoki Kumashiro ◽  
Hiroshi Uchino ◽  
Azusa Yamato ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Japanese Patients ◽  
Efficacy And Safety ◽  
Open Label

scholarly journals Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial

Diabetes Care ◽  
2017 ◽  
Vol 41 (2) ◽  
pp. 258-266 ◽  
Author(s):  
Andrew J. Ahmann ◽  
Matthew Capehorn ◽  
Guillaume Charpentier ◽  
Francesco Dotta ◽  
Elena Henkel ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Clinical Trial ◽  
Randomized Clinical Trial ◽  
Efficacy And Safety ◽  
Open Label
Sign in / Sign up

Export Citation Format

Share Document